Berman Richard J
Director at CYRX; Director at BIVI; Director at Advaxis, Inc., and 3 more
- Sold, on record
- $7.2M
- Dollars the filings state
- Form 4 sales
- 31
- Latest May 15, 2024
- Form 144 notices
- 2
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 6
- Filed as an executive or holder
Companies
- CYRXCryoport, Inc.Director
- BIVIBIOVIE INC.Director
- Advaxis, Inc.Director
- LSTALISATA THERAPEUTICS, INC.Director
- EASYLINK SERVICES INTERNATIONAL CORPDirector
- NEXMED INCDirector
Sales by reason
0
Routine
6
Plan not stated
3
No plan
22
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- Advaxis, Inc.1.5M shares
- LSTA415,252 shares
- EASYLINK SERVICES INTERNATIONAL CORP308,107 shares
- CYRX198,662 shares
- NEXMED INC61,873 shares
- BIVI32,773 shares
Shares sold, every Form 4 sale on record.
Timeline
- May 15, 2024No plan
Sold 7.5% of their holdings
$109k8,105 shares at $13.41
- May 15, 2024Notice
Filed a notice to sell 8,105 shares
$109k8,105 shares
- Aug 22, 2023Unusual
Sold 39.2% of their holdings
$38k10,805 shares at $3.50
- Jun 7, 2023Unusual
Sold 32.1% of their holdings
$67k10,984 shares at $6.12
- May 11, 2023No plan
Sold 6.7% of their holdings
$155k7,203 shares at $21.51
- May 11, 2023Notice
Filed a notice to sell 7,203 shares
$155k7,203 shares
- Mar 28, 2023No plan
Sold 24.3% of their holdings
$94k10,984 shares at $8.52
- Dec 1, 2022Unusual
Sold 100% of their holdings
$142k7,250 shares at $19.63
- Aug 16, 2022Plan not stated
Sold 2.5% of their holdings
$117k2,708 shares at $43.05
- Sep 15, 2021Plan not stated
Sold 20% of their holdings
$1.6M25,000 shares at $64.00
10 of 33
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | Jan 7, 2025 | BIVI | Director | AwardedStock Option (right to buy) | 23,155 | 23,155 | SEC | ||
| Dec 19, 2024 | Jan 6, 2025 | CELU | Director | AwardedStock Option (Right to Buy) | 84,746 | 202,857 | SEC | ||
| Dec 19, 2024 | Jan 6, 2025 | CELU | Director | Awarded | 67,416 | 67,416 | SEC | ||
| Nov 20, 2024 | Jan 7, 2025 | BIVI | Director | Awarded | 34,200 | 40,643 | SEC | ||
| Aug 27, 2024 | Aug 28, 2024 | CELU | Director | AwardedStock Option Grant (Right to Buy) | 118,111 | 118,111 | SEC | ||
| Jun 13, 2024 | Jun 14, 2024 | CNTX | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 17, 2024 | May 21, 2024 | CYRX | Director | AwardedOption (Right to Buy Common Stock) | 23,830 | 23,830 | SEC | ||
| May 17, 2024 | May 21, 2024 | CYRX | Director | Awarded | 12,845 | 112,845 | SEC | ||
| May 15, 2024 | May 16, 2024 | CYRX | Director | Sold | 8,105 | $13.41 | $109k | 100,000 | SEC |
| Nov 9, 2023 | Dec 6, 2023 | BIVI | Director | Awarded | 51,830 | 69,235 | SEC | ||
| Aug 22, 2023 | Aug 24, 2023 | BIVI | Director | Sold | 10,805 | $3.50 | $38k | 16,789 | SEC |
| Jun 7, 2023 | Jun 15, 2023 | BIVI | Director | Sold | 10,984 | $6.12 | $67k | 23,210 | SEC |
| May 31, 2023 | May 31, 2023 | CNTX | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| May 12, 2023 | May 16, 2023 | CYRX | Director | AwardedOption (Right to Buy Common Stock) | 15,125 | 15,125 | SEC | ||
| May 12, 2023 | May 16, 2023 | CYRX | Director | Awarded | 8,105 | 108,105 | SEC | ||
| May 11, 2023 | May 12, 2023 | CYRX | Director | Sold | 7,203 | $21.51 | $155k | 100,000 | SEC |
| Mar 28, 2023 | Apr 6, 2023 | BIVI | Director | Sold | 10,984 | $8.52 | $94k | 34,194 | SEC |
| Dec 1, 2022 | Dec 5, 2022 | CYRX | Director | Sold | 7,250 | $19.63 | $142k | 0 | SEC |
| Nov 23, 2022 | Jan 18, 2023 | BIVI | Director | Awarded | 43,578 | 45,178 | SEC | ||
| Aug 16, 2022 | Aug 16, 2022 | CYRX | Director | Sold | 2,708 | $43.05 | $117k | 107,203 | SEC |
| Jun 2, 2022 | Jun 3, 2022 | CNTX | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| Apr 30, 2022 | May 3, 2022 | CYRX | Director | Exercised or settledRestricted Stock Rights | 2,708 | 0 | SEC | ||
| Apr 30, 2022 | May 3, 2022 | CYRX | Director | Exercised options | 2,708 | 109,911 | SEC | ||
| Apr 29, 2022 | May 3, 2022 | CYRX | Director | AwardedOption (Right to Buy Common Stock) | 13,981 | 13,981 | SEC | ||
| Apr 29, 2022 | May 3, 2022 | CYRX | Director | Awarded | 7,203 | 107,203 | SEC | ||
| Apr 5, 2022 | Apr 20, 2022 | BIVI | Director | AwardedStock Option (right to buy) | 129,050 | 129,050 | SEC | ||
| Sep 15, 2021 | Sep 15, 2021 | CYRX | Director | Sold | 25,000 | $64.00 | $1.6M | 100,000 | SEC |
| Sep 13, 2021 | Sep 15, 2021 | CYRX | Director | Exercised or settledOptions to purchase common stock | 25,000 | 24,134 | SEC | ||
| Sep 13, 2021 | Sep 15, 2021 | CYRX | Director | Exercised options | 25,000 | $15.95 | $399k | 125,000 | SEC |
| Apr 30, 2021 | May 7, 2021 | CYRX | Director | AwardedOption to purchase common stock | 8,124 | 2,708 | SEC | ||
| Apr 7, 2021 | Apr 9, 2021 | CYRX | Director | Exercised or settledOptions to purchase common stock | 27,789 | 0 | SEC | ||
| Apr 7, 2021 | Apr 9, 2021 | CYRX | Director | Exercised options | 27,789 | $13.09 | $364k | 100,000 | SEC |
| Apr 5, 2021 | Apr 6, 2021 | Titan Environmental Solutions Inc. | Director | Awarded | 250,000 | 350,000 | SEC | ||
| Apr 1, 2021 | Apr 6, 2021 | ComSovereign Holding Corp. | Director | AwardedStock Options (Right to Buy) | 225,000 | 225,000 | SEC | ||
| Mar 24, 2021 | Mar 25, 2021 | CYRX | Director | Exercised or settledOptions to purchase common stock | 51,129 | 6,923 | SEC | ||
| Mar 24, 2021 | Mar 25, 2021 | CYRX | Director | Exercised options | 51,129 | $7.51 | $384k | 72,211 | SEC |
| Feb 25, 2021 | Mar 1, 2021 | CYRX | Director | Exercised or settledOptions to purchase common stock | 21,082 | 18,885 | SEC | ||
| Feb 25, 2021 | Mar 1, 2021 | CYRX | Director | Exercised options | 21,082 | $4.74 | $100k | 21,082 | SEC |
| Feb 11, 2021 | Feb 16, 2021 | OTRK | Director | AwardedOption (right to buy) | 4,882 | 4,882 | SEC | ||
| Dec 18, 2020 | Sep 29, 2021 | BIVI | Director | AwardedStock Option (right to buy) | 103,300 | 102,500 | SEC | ||
| Nov 11, 2020 | Nov 13, 2020 | CYRX | Director | Sold | 20,000 | $55.55 | $1.1M | 0 | SEC |
| Nov 11, 2020 | Nov 13, 2020 | CYRX | Director | Exercised or settledOptions to purchase common stock | 20,000 | 4,967 | SEC | ||
| Nov 11, 2020 | Nov 13, 2020 | CYRX | Director | Exercised options | 20,000 | $3.94 | $79k | 20,000 | SEC |
| Jul 29, 2020 | Jul 31, 2020 | CYRX | Director | Exercised or settledWarrants to purchase common stock | 8,138 | 0 | SEC | ||
| Jul 29, 2020 | Jul 31, 2020 | CYRX | Director | Exercised options | 8,138 | $3.57 | $29k | 9,250 | SEC |
| May 28, 2020 | Jun 2, 2020 | CYRX | Director | Exercised or settledWarrants to purchase common stock | 1,112 | 0 | SEC | ||
| May 28, 2020 | Jun 2, 2020 | CYRX | Director | Exercised options | 1,112 | $6.00 | $7k | 1,112 | SEC |
| May 4, 2020 | May 5, 2020 | Advaxis, Inc. | Director | AwardedOption | 13,000 | 13,000 | SEC | ||
| May 1, 2020 | May 5, 2020 | CYRX | Director | AwardedOptions to purchase common stock | 35,000 | 35,000 | SEC | ||
| Jan 2, 2020 | Sep 29, 2021 | BIVI | Director | Awarded | 1,600 | 1,600 | SEC |
Page 1
Sales and notices (33)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | May 16, 2024 | CYRX | Director | Form 4 sale | 8,105 | $109k | 7.5% | No plan | SEC |
| May 15, 2024 | May 15, 2024 | CYRX | Director | Form 144 notice | 8,105 | $109k | Notice | SEC | |
| Aug 22, 2023 | Aug 24, 2023 | BIVI | Director | Form 4 sale | 10,805 | $38k | 39.2% | Unusual | SEC |
| Jun 7, 2023 | Jun 15, 2023 | BIVI | Director | Form 4 sale | 10,984 | $67k | 32.1% | Unusual | SEC |
| May 11, 2023 | May 12, 2023 | CYRX | Director | Form 4 sale | 7,203 | $155k | 6.7% | No plan | SEC |
| May 11, 2023 | May 11, 2023 | CYRX | Director | Form 144 notice | 7,203 | $155k | Notice | SEC | |
| Mar 28, 2023 | Apr 6, 2023 | BIVI | Director | Form 4 sale | 10,984 | $94k | 24.3% | No plan | SEC |
| Dec 1, 2022 | Dec 5, 2022 | CYRX | Director | Form 4 sale | 7,250 | $142k | 100.0% | Unusual | SEC |
| Aug 16, 2022 | Aug 16, 2022 | CYRX | Director | Form 4 sale | 2,708 | $117k | 2.5% | Plan not stated | SEC |
| Sep 15, 2021 | Sep 15, 2021 | CYRX | Director | Form 4 sale | 25,000 | $1.6M | 20.0% | Plan not stated | SEC |
| Nov 11, 2020 | Nov 13, 2020 | CYRX | Director | Form 4 sale | 20,000 | $1.1M | 100.0% | Unusual | SEC |
| Nov 19, 2019 | Nov 21, 2019 | CYRX | Director | Form 4 sale | 5,000 | $75k | 100.0% | Unusual | SEC |
| Nov 15, 2019 | Nov 15, 2019 | CYRX | Director | Form 4 sale | 10,000 | $152k | 100.0% | Unusual | SEC |
| Mar 15, 2019 | Mar 18, 2019 | CYRX | Director | Form 4 sale | 30,000 | $355k | 100.0% | Unusual | SEC |
| Nov 15, 2018 | Nov 16, 2018 | CYRX | Director | Form 4 sale | 30,000 | $302k | 100.0% | Unusual | SEC |
| Sep 6, 2018 | Sep 7, 2018 | CYRX | Director | Form 4 sale | 10,000 | $140k | 100.0% | Unusual | SEC |
| Aug 15, 2018 | Aug 17, 2018 | CYRX | Chief Executive Officer | Form 4 sale | 20,000 | $256k | 100.0% | Unusual | SEC |
| May 25, 2018 | May 31, 2018 | CYRX | Director | Form 4 sale | 2,000 | $24k | 24.6% | Plan not stated | SEC |
| Aug 15, 2017 | Aug 22, 2017 | CYRX | Director | Form 4 sale | 21,396 | $165k | 100.0% | Unusual | SEC |
| Aug 9, 2016 | Aug 10, 2016 | Advaxis, Inc. | Director | Form 4 sale | 33,761 | $521k | 40.0% | Unusual | SEC |
| May 9, 2014 | May 9, 2014 | Advaxis, Inc. | Director | Form 4 sale | 14,530 | $38k | 100.0% | Unusual | SEC |
| Dec 12, 2013 | Dec 13, 2013 | LSTA | Director | Form 4 sale | 12,218 | $73k | 100.0% | Unusual | SEC |
| Dec 28, 2012 | Jan 18, 2013 | LSTA | Director | Form 4 sale | 149,306 | $88k | 50.4% | Unusual | SEC |
| Nov 23, 2012 | Jul 10, 2013 | Advaxis, Inc. | Director | Form 4 sale | 677,632 | $27k | 100.0% | Unusual | SEC |
| Sep 18, 2012 | Sep 18, 2012 | LSTA | Director | Form 4 sale | 36,000 | $25k | 19.4% | Plan not stated | SEC |
| Jul 15, 2011 | Jul 19, 2011 | EASYLINK SERVICES INTERNATIONAL CORP | Director | Form 4 sale | 39,474 | $229k | 45.0% | Unusual | SEC |
| Jul 15, 2011 | Jul 19, 2011 | EASYLINK SERVICES INTERNATIONAL CORP | Director | Form 4 sale | 113,026 | $637k | 56.3% | Unusual | SEC |
| Jul 14, 2011 | Jul 18, 2011 | EASYLINK SERVICES INTERNATIONAL CORP | Director | Form 4 sale | 5,000 | $29k | 9.4% | Plan not stated | SEC |
| Aug 18, 2010 | Aug 20, 2010 | LSTA | Director | Form 4 sale | 80,000 | $120k | 100.0% | Unusual | SEC |
| Mar 9, 2010 | Mar 11, 2010 | NEXMED INC | Director | Form 4 sale | 61,873 | $31k | 16.8% | Plan not stated | SEC |
| Feb 12, 2010 | Feb 19, 2010 | Advaxis, Inc. | Director | Form 4 sale | 760,624 | $122k | 100.0% | Unusual | SEC |
| Jan 8, 2010 | Jan 8, 2010 | LSTA | Director | Form 4 sale | 137,728 | $150k | 63.3% | Unusual | SEC |
| Dec 12, 2008 | Dec 16, 2008 | EASYLINK SERVICES INTERNATIONAL CORP | Director | Form 4 sale | 150,607 | $164k | 77.6% | Unusual | SEC |